Trevi Therapeutics, Inc. - Common Stock, $0.001 par value per share (TRVI)

CUSIP: 89532M101

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
143,562,667
Total 13F shares
51,561,502
Share change
-551,621
Total reported value
$177,886,781
Put/Call ratio
27%
Price per share
$3.45
Number of holders
79
Value change
-$90,828
Number of buys
37
Number of sells
30

Security key

89532M101

Report period

Q1 2024

Institutions

79

Top holders

10

Top shareholders of TRVI - Trevi Therapeutics, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
NEA Management Company, LLC
13F
Company
7.9%
11,370,376
$15,236,304 31 Dec 2023
13F
Frazier Life Sciences Management, L.P.
13F
Company
5.1%
7,381,090
$9,890,661 31 Dec 2023
13F
TPG GP A, LLC
3/4/5
Former 10% Owner
class O/S missing
3,824,883
$7,726,264 01 Jul 2022
Rubric Capital Management LP
13F
Company
4%
5,684,420
$7,617,123 31 Dec 2023
13F
VIKING GLOBAL INVESTORS LP
13F
Company
3.1%
4,400,000
$5,896,000 31 Dec 2023
13F
VR Adviser, LLC
13F
Company
2.4%
3,422,397
$4,586,012 31 Dec 2023
13F
Opaleye Management Inc.
13F
Company
1.8%
2,535,000
$3,396,900 31 Dec 2023
13F
BlackRock Finance, Inc.
13F
Company
1.6%
2,319,716
$3,108,419 31 Dec 2023
13F
VANGUARD GROUP INC
13F
Company
1.6%
2,243,399
$3,006,154 31 Dec 2023
13F
Rosalind Advisors, Inc.
13F
Company
1.3%
1,862,425
$2,495,650 31 Dec 2023
13F
Peter W. Sonsini
3/4/5
10%+ Owner
mixed-class rows
3,948,948
mixed-class rows
$1,916,875 11 Apr 2022
Checkpoint Capital L.P.
13F
Company
0.9%
1,292,316
$1,731,703 31 Dec 2023
13F
MAI Capital Management
13F
Company
0.89%
1,279,458
$1,714,474 31 Dec 2023
13F
Tejara Capital Ltd
13F
Company
0.88%
1,269,000
$1,700,460 31 Dec 2023
13F
LANDSCAPE CAPITAL MANAGEMENT, L.L.C.
13F
Company
0.63%
910,094
$1,219,526 31 Dec 2023
13F
SILVERARC CAPITAL MANAGEMENT, LLC
13F
Company
0.6%
863,883
$1,157,603 31 Dec 2023
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.59%
849,881
$1,138,963 31 Dec 2023
13F
STATE STREET CORP
13F
Company
0.52%
741,193
$993,199 31 Dec 2023
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.38%
542,700
$727,000 31 Dec 2023
13F
Anson Funds Management LP
13F
Company
0.29%
420,803
$563,876 31 Dec 2023
13F
NORTHERN TRUST CORP
13F
Company
0.22%
314,178
$420,999 31 Dec 2023
13F
TANG CAPITAL MANAGEMENT LLC
13F
Company
0.21%
300,000
$402,000 31 Dec 2023
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.15%
211,481
$283,385 31 Dec 2023
13F
CITADEL ADVISORS LLC
13F
Company
0.13%
185,058
$247,977 31 Dec 2023
13F
MORGAN STANLEY
13F
Company
0.1%
149,003
$199,664 31 Dec 2023
13F
J. Goldman & Co LP
13F
Company
0.1%
137,873
$184,750 31 Dec 2023
13F
Bank of New York Mellon Corp
13F
Company
0.09%
133,381
$178,731 31 Dec 2023
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0.09%
132,209
$177,160 31 Dec 2023
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.08%
119,793
$160,523 31 Dec 2023
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.08%
107,707
$144,327 31 Dec 2023
13F
Squarepoint Ops LLC
13F
Company
0.07%
99,491
$133,318 31 Dec 2023
13F
PFS Partners, LLC
13F
Company
0.07%
99,000
$132,660 31 Dec 2023
13F
SG Americas Securities, LLC
13F
Company
0.07%
98,253
$132,000 31 Dec 2023
13F
Nuveen Asset Management, LLC
13F
Company
0.05%
74,849
$100,298 31 Dec 2023
13F
JANE STREET GROUP, LLC
13F
Company
0.05%
65,953
$88,377 31 Dec 2023
13F
BARCLAYS PLC
13F
Company
0.04%
63,797
$85,488 31 Dec 2023
13F
WealthTrust Axiom LLC
13F
Company
0.04%
63,500
$85,090 31 Dec 2023
13F
RHUMBLINE ADVISERS
13F
Company
0.04%
51,464
$68,954 31 Dec 2023
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.03%
41,992
$56,269 31 Dec 2023
13F
Atom Investors LP
13F
Company
0.03%
39,648
$53,128 31 Dec 2023
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.03%
36,702
$49,181 31 Dec 2023
13F
TRUST CO OF TOLEDO NA /OH/
13F
Company
0.03%
36,502
$48,913 31 Dec 2023
13F
UBS Group AG
13F
Company
0.02%
31,377
$42,045 31 Dec 2023
13F
UNITED BANK
13F
Company
0.02%
28,450
$38,123 31 Dec 2023
13F
JPMORGAN CHASE & CO
13F
Company
0.02%
26,983
$36,157 31 Dec 2023
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.02%
23,915
$32,046 31 Dec 2023
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.01%
21,063
$28,224 31 Dec 2023
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0.01%
20,951
$28,074 31 Dec 2023
13F
Invesco Ltd.
13F
Company
0.01%
19,888
$26,650 31 Dec 2023
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.01%
17,207
$23,057 31 Dec 2023
13F

Institutional Holders of Trevi Therapeutics, Inc. - Common Stock, $0.001 par value per share (TRVI) as of Q1 2024

As of 31 Mar 2024, Trevi Therapeutics, Inc. - Common Stock, $0.001 par value per share (TRVI) was held by 79 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 51,561,502 shares. The largest 10 holders included NEA Management Company, LLC, Frazier Life Sciences Management, L.P., Rubric Capital Management LP, VIKING GLOBAL INVESTORS LP, VR Adviser, LLC, Opaleye Management Inc., BlackRock Inc., VANGUARD GROUP INC, Logos Global Management LP, and MPM BIOIMPACT LLC. This page lists 79 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 holders
62
Q1 2024 holders
79
Holder diff
17
Investor Q4 2023 Shares Q1 2024 Shares Share Diff Share Chg % Q4 2023 Value $ Q1 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .